Evidence Summary
- Evidence Level
- Moderate
- Mechanism
- Enrollment: Actual, Enrollment: Estimated, Sponsor Type: Other, Sponsor Type: Other Gov
- Safety
- Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
- Dosing
- See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 5 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.
Clinical Trials
5 trial(s) registered
| NCT ID | Title | Phase | Status |
|---|---|---|---|
| NCT06452095 | Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of P | Not applicable | Recruiting |
| NCT04842448 | Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome | Phase 2 | Completed |
| NCT06267300 | Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial | Phase 3 | Unknown status |
| NCT04905888 | Hyperbaric Oxygen for Long COVID-19 Pulmonary Sequela | Phase 2 | Withdrawn |
| NCT07621068 | Hyperbaric Oxygen Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | Not applicable | Recruiting |
Key Studies / References
- See linked studies